Skip to Content

CL 23 (Fenofibrate (Micronized) 134 mg)

Pill with imprint CL 23 is Yellow & White, Capsule-shape and has been identified as Fenofibrate (Micronized) 134 mg. It is supplied by Alvogen, Inc..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL 23

Fenofibrate (Micronized)

Imprint
CL 23
Strength
134 mg
Color
Yellow & White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alvogen, Inc.
National Drug Code (NDC)
47781-0519
Inactive Ingredients
sodium lauryl sulfate, croscarmellose sodium, corn starch, microcrystalline cellulose, silicon dioxide, sodium stearyl fumarate, titanium dioxide, FD&C Yellow No. 6, D&C Yellow No. 10, shellac, potassium hydroxide, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "CL 23"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.